ANI Pharmaceuticals (ANIP) News Today $56.91 +1.05 (+1.88%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Thompson Siegel & Walmsley LLC Has $13.73 Million Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Thompson Siegel & Walmsley LLC increased its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 17.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 230,159 shares of theNovember 21 at 8:25 AM | marketbeat.comANI Pharmaceuticals Advances Amidst Regulatory and Market ChallengesNovember 21 at 1:42 AM | markets.businessinsider.comGlobal Alpha Capital Management Ltd. Has $32.01 Million Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Global Alpha Capital Management Ltd. raised its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 1.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 536,450 shares of the specialty pharmaceutical company's stock after acquiringNovember 20 at 7:51 AM | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Sees Significant Growth in Short InterestANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 2,160,000 shares, an increase of 5.4% from the October 15th total of 2,050,000 shares. Based on an average daily volume of 310,500 shares, the days-to-cover ratio is presently 7.0 days.November 17, 2024 | marketbeat.comMizuho Markets Americas LLC Buys Shares of 195,613 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Mizuho Markets Americas LLC purchased a new stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 195,613 shares of the specialty pharmaceutical company's stock, vNovember 16, 2024 | marketbeat.comANI Pharmaceuticals' (ANIP) Buy Rating Reiterated at HC WainwrightNovember 14, 2024 | americanbankingnews.comLisanti Capital Growth LLC Has $890,000 Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Lisanti Capital Growth LLC lessened its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 70.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 14,920 shares of the specialty pharmaceutical company's stock after selling 36,November 12, 2024 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | msn.comANI Pharmaceuticals: Buy Rating Backed by Consistent Revenue Growth, Strategic Acquisitions, and Strong Market PositionNovember 11, 2024 | markets.businessinsider.comTruist Financial Remains a Hold on ANI Pharmaceuticals (ANIP)November 11, 2024 | markets.businessinsider.comANI Pharmaceuticals (NASDAQ:ANIP) Given "Buy" Rating at HC WainwrightHC Wainwright reissued a "buy" rating and set a $94.00 target price on shares of ANI Pharmaceuticals in a research report on Monday.November 11, 2024 | marketbeat.comSummit Global Investments Raises Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Summit Global Investments lifted its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 154.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,704 shares of the specialty pharmaceutical company's sNovember 9, 2024 | marketbeat.comANI Pharmaceuticals, Inc. (ANIP) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comANI Pharmaceuticals (NASDAQ:ANIP) Shares Gap Up - Here's WhyANI Pharmaceuticals (NASDAQ:ANIP) Shares Gap Up - Here's What HappenedNovember 8, 2024 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Releases FY24 Earnings GuidanceANI Pharmaceuticals (NASDAQ:ANIP) updated its FY24 earnings guidance. The company provided EPS guidance of $4.90-5.05 for the period, compared to the consensus estimate of $4.72. The company also issued revenue guidance of $594-602 millionillion, compared to the consensus estimate of $590.33 millionillion.November 8, 2024 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Updates FY 2024 Earnings GuidanceANI Pharmaceuticals (NASDAQ:ANIP) updated its FY 2024 earnings guidance. The company provided EPS guidance of 4.900-5.050 for the period, compared to the consensus estimate of 4.720. The company also issued revenue guidance of $594.0 millionillion-$602.0 millionillion, compared to the consensus estimate of $590.3 millionillion.November 8, 2024 | marketbeat.comANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 GuidanceNovember 8, 2024 | globenewswire.comANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To ExpectNovember 8, 2024 | finance.yahoo.comA Peek at ANI Pharmaceuticals's Future EarningsNovember 7, 2024 | benzinga.comANI Pharmaceuticals Q3 2024 Earnings PreviewNovember 7, 2024 | msn.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Recommendation of "Moderate Buy" from BrokeragesANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six research firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have assNovember 7, 2024 | marketbeat.comANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in NovemberNovember 4, 2024 | globenewswire.comF M Investments LLC Purchases Shares of 61,782 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)F M Investments LLC acquired a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 61,782 shares of the specialty pharmaceutical company's stock, valued at approxiNovember 3, 2024 | marketbeat.comANI Pharmaceuticals Is Acting Like It Is Being AcquiredNovember 2, 2024 | seekingalpha.comANI Pharmaceuticals (ANIP) Set to Announce Earnings on FridayANI Pharmaceuticals (NASDAQ:ANIP) will be releasing earnings before the market opens on Friday, November 8, Zacks reports.November 1, 2024 | marketbeat.comANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ETOctober 30, 2024 | globenewswire.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Short Interest Down 9.7% in OctoberANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) was the recipient of a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 2,050,000 shares, a drop of 9.7% from the September 30th total of 2,270,000 shares. Based on an average daily volume of 352,600 shares, the days-to-cover ratio is currently 5.8 days.October 30, 2024 | marketbeat.comTruist Financial Keeps Their Hold Rating on ANI Pharmaceuticals (ANIP)October 28, 2024 | markets.businessinsider.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Acquired by Assenagon Asset Management S.A.Assenagon Asset Management S.A. lifted its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 149.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 186,179 shares of the specialty pharmaceuticaOctober 28, 2024 | marketbeat.comANI Pharmaceuticals announces FDA approval of Estradiol Gel, 0.06%October 25, 2024 | markets.businessinsider.comANI Pharmaceuticals launches estradiol gel after final FDA approvalOctober 25, 2024 | msn.comANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%October 25, 2024 | globenewswire.comANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024October 24, 2024 | globenewswire.comTruist Financial Raises ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $62.00Truist Financial upped their price target on shares of ANI Pharmaceuticals from $60.00 to $62.00 and gave the stock a "hold" rating in a research note on Tuesday.October 22, 2024 | marketbeat.comANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?October 17, 2024 | finance.yahoo.comInsider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Sells 250 Shares of StockOctober 16, 2024 | insidertrades.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Sells $14,297.50 in StockANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) VP Meredith Cook sold 250 shares of the stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $57.19, for a total transaction of $14,297.50. Following the transaction, the vice president now owns 56,488 shares in the company, valued at approximately $3,230,548.72. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.October 15, 2024 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the six ratings firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and fivOctober 13, 2024 | marketbeat.comPiper Sandler Initiates Coverage of ANI Pharmaceuticals (ANIP) with Overweight RecommendationOctober 12, 2024 | msn.comPeeling Back The Layers: Exploring ANI Pharmaceuticals Through Analyst InsightsOctober 11, 2024 | benzinga.comANI earns bullish view at Piper Sandler on portfolio mixOctober 11, 2024 | msn.comANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong PotentialOctober 11, 2024 | finance.yahoo.comBuy Rating Affirmed: ANI Pharmaceuticals’ Transition to High-Margin Rare Disease Brands Fuels Growth PotentialOctober 11, 2024 | markets.businessinsider.comPiper Sandler Initiates Coverage on ANI Pharmaceuticals (NASDAQ:ANIP)Piper Sandler started coverage on shares of ANI Pharmaceuticals in a research note on Friday. They issued an "overweight" rating and a $68.00 target price on the stock.October 11, 2024 | marketbeat.comANI Pharmaceuticals: A Rare GARP Stock In An Overbought MarketOctober 11, 2024 | seekingalpha.comMillennium Management LLC Acquires 209,272 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Millennium Management LLC increased its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 1,005.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 230,079 shares of the specialty pharmaceutical company's stock after acquiring an aOctober 7, 2024 | marketbeat.comAlgert Global LLC Has $825,000 Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Algert Global LLC lowered its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 64.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,951 shares of the specialty pharmaceutical company's stock afterOctober 6, 2024 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Stock, Short Interest ReportOctober 3, 2024 | benzinga.comDimensional Fund Advisors LP Grows Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Dimensional Fund Advisors LP boosted its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 3.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 630,226 shares of the specialty pharmaceutical company's stock after buying an additOctober 1, 2024 | marketbeat.comMaverick Capital Ltd. Purchases 13,926 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Maverick Capital Ltd. grew its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 302.1% during the second quarter, according to its most recent filing with the SEC. The firm owned 18,536 shares of the specialty pharmaceutical company's stock after acquiring an additionaSeptember 28, 2024 | marketbeat.com Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address ⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price. Click here for the ticker >>> ANIP Media Mentions By Week ANIP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIP News Sentiment▼1.320.49▲Average Medical News Sentiment ANIP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIP Articles This Week▼55▲ANIP Articles Average Week Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CytomX Therapeutics News DURECT News Biohaven News BridgeBio Pharma News Ultragenyx Pharmaceutical News Immunovant News Organon & Co. News Rhythm Pharmaceuticals News ImmunityBio News Apellis Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIP) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
